Néphropathie diabétique: aspects thérapeutiques [Diabetic nephropathies: therapeutic aspects]

Détails

ID Serval
serval:BIB_492E1DC3C893
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Néphropathie diabétique: aspects thérapeutiques [Diabetic nephropathies: therapeutic aspects]
Périodique
Schweizerische Rundschau für Medizin Praxis
Auteur⸱e⸱s
Bulliard C., Fontana E., Ruiz J.
ISSN
0369-8394
Statut éditorial
Publié
Date de publication
12/2001
Volume
90
Numéro
51-52
Pages
2266-2271
Notes
21678804 1013-2058 Journal Article --- Old month value: Dec 20 --- Old uritopublisher value: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11820169
Résumé
The incidence of diabetic nephropathy has declined these last decades, but diabetes mellitus still remains the commonest cause of end-stage renal failure, due to an increased prevalence of diabetes mellitus and a longer life expectancy for diabetic patients. The aim of this review is to describe the natural history of diabetic nephropathy and discuss the influence of many factors such as genetic and non-genetic progression promoters, hypertension, hyperglycemia, dyslipidemia, proteinuria and tobacco. Because only a comprehensive treatment strategy of these promoters will reduce the risk of end-stage renal failure, the inclusion of cardiovascular risk factors management and the screening of cardiovascular disease will further contribute to reduce the very high mortality of diabetic patients suffering of diabetic nephropathy.
Mots-clé
Combined Modality Therapy Diabetic Nephropathies/diagnosis/etiology/*therapy English Abstract Human Kidney Function Tests Mass Screening Risk Factors
Pubmed
Création de la notice
03/03/2008 16:31
Dernière modification de la notice
20/08/2019 14:56
Données d'usage